The antiparasitic drug atovaquone enhanced the phosphorylation of eIF2α, increased ATF4 protein levels and transcription of ATF4 target genes, and inhibited mitochondrial OXPHOS, which resulted in growth arrest and apoptosis of AML patient cells (87). Here, ATF4 is linked to acute myeloid leukemia.